iSpecimen Inc
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers worldwide. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. Its marketplace offers human biospecim… Read more
iSpecimen Inc (ISPC) - Total Assets
Latest total assets as of September 2025: $9.00 Million USD
Based on the latest financial reports, iSpecimen Inc (ISPC) holds total assets worth $9.00 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
iSpecimen Inc - Total Assets Trend (2018–2024)
This chart illustrates how iSpecimen Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
iSpecimen Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
iSpecimen Inc's total assets of $9.00 Million consist of 38.4% current assets and 61.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 20.1% |
| Accounts Receivable | $1.44 Million | 15.5% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $5.33 Million | 57.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2024)
This chart illustrates how iSpecimen Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: iSpecimen Inc's current assets represent 38.4% of total assets in 2024, a decrease from 57.0% in 2018.
- Cash Position: Cash and equivalents constituted 20.1% of total assets in 2024, down from 28.0% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 56.0% of total assets, an increase from 35.0% in 2018.
- Asset Diversification: The largest asset category is intangible assets at 57.0% of total assets.
iSpecimen Inc Competitors by Total Assets
Key competitors of iSpecimen Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
iSpecimen Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - iSpecimen Inc generates 0.99x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - iSpecimen Inc is currently not profitable relative to its asset base.
iSpecimen Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.63 | 0.74 | 0.16 |
| Quick Ratio | 0.63 | 0.74 | 0.16 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-2.10 Million | $ -1.61 Million | $ -18.66 Million |
iSpecimen Inc - Advanced Valuation Insights
This section examines the relationship between iSpecimen Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.96 |
| Latest Market Cap to Assets Ratio | 0.23 |
| Asset Growth Rate (YoY) | -40.9% |
| Total Assets | $9.35 Million |
| Market Capitalization | $2.16 Million USD |
Valuation Analysis
Below Book Valuation: The market values iSpecimen Inc's assets below their book value (0.23 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: iSpecimen Inc's assets decreased by 40.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for iSpecimen Inc (2018–2024)
The table below shows the annual total assets of iSpecimen Inc from 2018 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $9.35 Million | -40.89% |
| 2023-12-31 | $15.82 Million | -35.74% |
| 2022-12-31 | $24.62 Million | -31.08% |
| 2021-12-31 | $35.72 Million | +475.22% |
| 2020-12-31 | $6.21 Million | +47.34% |
| 2019-12-31 | $4.21 Million | +4.20% |
| 2018-12-31 | $4.04 Million | -- |